FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula 
(I) in free form or in form of a pharmaceutically acceptable salt, where A is independently selected from CH and at least one nitrogen atom; D denotes CR3; R1 and R2 denote H, R3 denotes C1-C8-alkyl, R5 denotes 
, R5j and R5k are independently selected from H, C1-C8-alkyl and C3-C15-carbocyclic group, or R5j and R5k together with the nitrogen atom to which they are bonded form an optionally substituted 4-14-member heterocyclic group; R6 denotes H; W denotes a C6-C15-aromatic carbocyclic group; X denotes -CH2-; n assumes values from 0 to 3, a pharmaceutical composition based on said compounds and having CRTh2 receptor modulating activity, as well as a method for synthesis of compounds of formula I.
EFFECT: novel compounds which can be used as anti-inflammatory agents are obtained and described.
9 cl, 1 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THIAZOLE DERIVATIVES AS A2B ANTAGONISTS | 2005 |
|
RU2374242C2 |
| 2,3-SUBSTITUTED PYRAZINE SULPHONAMIDES AS CRTH2 INHIBITORS | 2006 |
|
RU2453540C2 |
| COMPOUNDS HAVING CRTH2 ANTAGONIST ACTIVITY | 2009 |
|
RU2503672C2 |
| APPLICATION OF CRTH2 ANTAGONISTS IN THERAPY | 2004 |
|
RU2412934C2 |
| ANTHELMINTHIC DEPSIPEPTIDE COMPOUNDS | 2016 |
|
RU2715556C2 |
| MEDICINAL AGENT BASED ON THIAZOLE OR THIADIAZOLE DERIVATIVES, THIAZOLE OR THIADIAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2173687C2 |
| HETEROCYCLIC COMPOUNDS AS CRTH2 RECEPTOR ANTAGONISTS | 2008 |
|
RU2451019C2 |
| ACIDIFIED ARYLCYCLOALKYLAMINS AND THEIR APPLICATION AS PHARMACEUTICAL DRUGS | 2003 |
|
RU2337094C2 |
| DERIVATIVES OF PYRAZOLE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF AND INTERMEDIATE COMPOUNDS OF SYNTHESIS | 1993 |
|
RU2119917C1 |
| HETEROCYCLIC AMIDE COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD FOR PREPARATION AND USE THEREOF | 2020 |
|
RU2823875C1 |
